Abstract:PURPOSE To explore and evaluate the protective effect of erythropoietin (EPO) on retinal cells of chemically induced diabetic rats after EPO was injected intravitreally at the onset of diabetes. METHODS Diabetes was induced in Sprague-Dawley rats by intraperitoneal injection of streptozotocin (STZ). At the onset of diabetes, a single intravitreal injection of EPO (0.05-200 ng/eye) was performed. In the following 6 weeks, the blood retinal barrier (BRB) was evaluated by Evans blue permeation (EBP). Retinal cell death in different layers was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining. The retinal thickness and cell counts were examined at the light microscopic level. Electron microscopy (EM) was used to scrutinize retinal vascular and neuronal injury. Neurosensory retinas of normal and diabetic rats were used as the sources of reverse transcription-polymerase chain reaction (RT-PCR) and Western blot for the detection of EPO, EPO receptor (EpoR), and products of the extracellular signal-regulated kinase (ERK) and the signal transducers and activators of transcription 5 (STAT5) pathways. The distribution of EpoR in retinal layers was demonstrated by immunohistochemistry (IHC). RESULTS In the diabetic rats, BRB breakdown was detected soon after the onset of diabetes, peaked at 2 weeks, and reached a plateau at 2 to 4 weeks. The number of TUNEL-positive cells increased in the neurosensory retina, especially, the outer nuclear layer (ONL) at 1 week after diabetes onset and reached a peak at 4 to 6 weeks. The retinal thickness and the number of cells in the ONL were reduced significantly. EM observations demonstrated vascular and photoreceptor cell death starting soon after the onset of diabetes. All these changes were largely prevented by EPO treatment. Upregulation of EpoR in the neurosensory retina was detected at both the transcriptional and protein levels 4 to 8 weeks after the onset of diabetes, whereas, the endogenous EPO levels of neurosensory retinas were essentially unchanged during the same period observed. In EPO-treated diabetic groups, EpoR expression remained at upregulated levels. Within 2 weeks of the onset of diabetes, activation of the ERK but not the STAT5 pathway was detected in the diabetic retina treated with EPO. CONCLUSIONS These data demonstrate that apoptosis is an major contributor to neuronal cell death in the early course of diabetic retinopathy (DR). The upregulation of EpoR may be a compensatory response of retinal cells and tissue to diabetic stresses. The EPO/EpoR system as a maintenance-survival mechanism of retinal neurons responds to the insults of early diabetes other than ischemia. The protective function of EPO/EpoR at the least acts through the EpoR-mediated ERK pathway. Exogenous EPO administration by intravitreal injection in early diabetes may prevent retinal cell death and protect the BRB function. Therefore, this is a novel approach for treatment of early DR.

Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats.

Safety and Efficacy of Intravitreal Injection of Recombinant Erythropoietin for Protection of Photoreceptor Cells in a Rat Model of Retinal Detachment

Intravitreal Injection of Erythropoietin Sustained-Release Microspheres Protects Damaged Retinal Ganglion Cells in Rats

Protection of Endogenous Erythropoietin on Photoreceptor Cells in Retinal Detachment and Its Mechanism

Effect of Erythropoietin on Signal Transduction Pathway in Rat Model of Retinal Detachment

Protective Effects of Recombinant Erythropoietin on Photoreceptor Cells in Rat with Retinal Detachment

[The Effects of Recombinant Human Erythropoietin on Electroretinogram after Raising Intraocular Pressure in Rabbits].

[Effect of Recombinant Human Erythropoietin on Bcl-2 Protein Expression in the Retina in a Rabbit Model of Acute High Intraocular Pressure].

[Effects of Recombinant Human Erythropoietin on Hypoxia Inducible Factor-1Alpha Expression in the Retina of Rabbits with Acute High Intraocular Pressure].

Effect of exogenous erythropoietin soluble receptor on survival of retinal neurons

Intravitreal Injection of Erythropoietin Protects Both Retinal Vascular and Neuronal Cells in Early Diabetes

Effects of Recombinant Human Erythropoietin on Glutamate Expression in the Retina with Acute High Intraocular Pressure in a Rabbit Model

Effects of Erythropoietin-Dextran Microparticle-Based Plga/Pla Microspheres on Rgcs

Pharmacokinetic and Toxicity Study of Intravitreal Erythropoietin in Rabbits

Recombinant Human Erythropoietin Administration Protects Retinal Structure Against Ischemia and Reperfusion Injury in Rabbits

Protection of systemic recombinant human erythropoietin on the ultrastructure of retina and optic nerve in an acute high intraocular pressure rabbit model

Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy

Erythropoietin Receptor Antibody Inhibits Oxidative Stress Induced Retinal Neovascularization In Mice

PROTECTION MECHANISM OF ERYTHROPOIETIN ON CERAMIDE-INDUCED RETINAL DAMAGE

Intraperitoneal Injection of Ginkgo Biloba Extract Enhances Antioxidation Ability of Retina and Protects Photoreceptors after Light-Induced Retinal Damage in Rats

Expression Pattern of Erythropoietin and Erythropoietin Receptor in Experimental Model of Retinal Detachment